Sonidegib-[d4] (morphonyl-[d4])

Sonidegib-[d4] (morphonyl-[d4]) is a labelled form of Sonidegib. Sonidegib is an orally bioavailable small-molecule Smoothened (Smo) antagonist with potential antineoplastic activity. It was approved by the FDA for treating basal-cell carcinoma in July 2015.
Supplier BOC Sciences
Product # BLP-004261
Pricing Inquire
Molecular Weight 489.52
Molecular Formula C26H22D4F3N3O3
Feedback